Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. (Q42683340)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 January 2013

Language	Label	Description	Also known as
English	Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.	scientific article published on 17 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

14

object named as

Bonnie Vlahos

1 reference

Europe PubMed Central

PubMed publication ID

22 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

3

object named as

Patrick Durez

1 reference

Europe PubMed Central

PubMed publication ID

22 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

Annette Szumski

11

object named as

Annette Szumski

1 reference

Europe PubMed Central

PubMed publication ID

22 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

author name string

Stephen Hall

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Elena Ilivanova

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Fedra Irazoque-Palazuelos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pedro Miranda

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ronald Pedersen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Constance Hammond

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Andrew S Koenig

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Josef S Smolen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

0 references

publication date

17 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

381

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

9870

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

918-929

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating rheumatoid arthritis to target: recommendations of an international task force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing remission in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Path to Personalized Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22-23, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease-modifying anti-rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community-based practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors of work disability in rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity--the early RA network (ERAN)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961811-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61811-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

release_wlpyzlq5ujdipgwnyuzruybzje

1 reference

https://api.fatcat.wiki/v0/release/wlpyzlq5ujdipgwnyuzruybzje

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23332236%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42683340&oldid=2115042094"